Molecular characterization of enteroviruses isolated from acute flaccid paralysis cases in Poland, 1999-2014

• Autorzy: Wieczorek M. , Krzysztoszek A.
• Języki publikacji: EN

Abstrakty

EN

Enteroviruses (EVs) are among viral pathogens that can cause acute flaccid paralysis (AFP). This study represents an overview of EVs isolated through AFP surveillance in Poland between 1999 and 2014. The presence of enteroviruses was studied in stool samples that were collected from 747 AFP cases and their asymptomatic contacts. Fifty five (6.12%) cases of AFP were associated with enterovirus isolation. Out of the 55 positive cases, 40 were associated with detection of enterovirus in patient, and 15 with detection of EV in healthy contact, without positive detection in paralytic patient. Polioviruses were isolated from 35 AFP cases. The results of this study showed that about 43.6% of positive AFP cases were found in association with the isolation of non-polio enteroviruses (NPEV). A total of 12 different types of the species B were detected (CVA9, CVB1, CVB3, CVB4, CVB5, E3, E4, E9, E11, E13, E30), and one additional isolate representedthe species enterovirus A (EV71). Among the 12 serotypes of species B, CVB3 and CVB5 were more frequently detected than others, representing 40% of the characterized isolates, followed by CVB4 (16%), E4 (8%), and E11(8%). Phylogenetic analysis revealed that strains from Poland had the closest genetic relationship with isolates previously identified in Europe (France, Finland, Denmark, Moldova) but also in other parts of the world (Tunisia, China, USA), suggesting wide distribution of these lineages. The paper provides information about NPEV circulation in Poland in the past 16 years, about its association with the AFP and it indicates the need for monitoring NPEV circulation even after the eradication of poliomyelitis.

• Wydawca: -
• Czasopismo: Polish Journal of Microbiology
• Rocznik: 2016
• Tom: 65
• Numer: 4
• Opis fizyczny: p.443-450,fig.,ref.

Twórcy

autor

Wieczorek M.

• Department of Virology, National Institute of Public Health - National Institute of Hygiene, Warsaw, Poland

autor

Krzysztoszek A.

• Department of Virology, National Institute of Public Health - National Institute of Hygiene, Warsaw, Poland

Bibliografia

• Angez M., S. Shaukat, R. Zahra, A. Khurshid, S. Sharif, M.M. Alam and S.S. Zaidi. 2015. Molecular epidemiology of enterovirus B77 isolated from non polio acute flaccid paralytic patients in Pakistan during 2013. Infect. Genet. Evol. 29: 189–195.
• Apostol L.N., A. Suzuki, A. Bautista, H. Galang, F.J. Paladyn, N. Fuji, S. Lupisan, R. Olveda, and H. Oshitani. 2012. Detection of non-polio enteroviruses from 17 years of virological surveillance of acute flaccid paralysis in the Philippines. J. Med. Virol. 84: 624–631.
• Attoh J., E. Obodaj, T. Adiku and J.K. Odoom. 2014. Prevalence of human enteroviruses among apparently healthy nursery school children in Accra. Pan. Afr. Med. J. 18: 66.
• Bahri O., D. Rezig, B.B. Nejma-Oueslati, A.B. Yahia, J.B. Sassi, N. Hogga, A. Sadraoui and H. Triki. 2005. Enteroviruses in Tunisia: virological surveillance over 12 years (1992–2003). J. Med. Microbiol. 54: 63–69.
• Dhole T.N., A. Ayyagari, R. Chowdhary, A.K. Shakya, N. Shrivastay, T. Datta and V. Prakash. 2009. Non-polio enteroviruses in acute flaccid paralysis children of India: vital assessment before polio eradication. J. Paediatr. Child. Health 45: 409–413.
• Grist N.R. and E.J. Bell. 1984. Paralytic poliomyelitis and nonpolio enteroviruses: studies in Scotland. Rev. Infect. Dis. 6: 385–386.
• Halim S. and A.I. Ramsingh. 2000. A point mutation in VP1 of coxsackievirus B4 alters antigenicity. Virology 269:86–94.
• Hosoya M., H. Ishiko, Y. Shimada, K. Honzumi, S. Suzuki, K. Kato and H. Suzuki. 2002. Diagnosis of group A coxsackieviral infection using polymerase chain reaction. Arch. Dis. Child. 87: 316–319.
• Jarząbek Z., J. Żabicka, A. John, J. Howlett, G. Dunn and D.J. Wood. 1992. Application of monoclonal antibody panels in the virological and epidemiological review of poliomyelitis in Poland, 1981–1990. Bull World Health Organ. 70: 327–333.
• Kapoor A., A. Ayyagari and T.N. Dhole. 2001. Non-polio enteroviruses in acute flaccid paralysis. Indian J. Pediatr. 68: 927–929.
• Kapusinszky B., Z. Molnar, K.N. Szomor and G. Berencsi. 2010. Molecular characterization of poliovirus isolates from children who contracted vaccine-associated paralytic poliomyelitis (VAPP) following administration of monovalent type 3 oral poliovirus vaccine in the 1960s in Hungary. FEMS Immunol. Med. Microbiol. 58: 211–217.
• Kuramitsu M., C. Kuroiwa, H. Yoshida, M. Miyoshi, J. Okumura, H. Shimizu, L. Narantuya and D. Bat-Ochir. 2005. Non-polio enterovirus isolation among families in Ulaanbaatar and Tov province, Mongolia: prevalence, intrafamiliar spread, and risk factors for infection. Epidemiol. Infect. 133: 1131–1142.
• Lang M., A. Mirand, N. Savy, C. Henquell, S. Maridet, R. Perignon, A. Labbe and H. Peigue-Lafeuille. 2014. Acute flaccid paralysis following enterovirus D68 associated pneumonia, France, 2014. Euro. Surveill. 19:pii: 20952.
• Laxmivandana R., P. Yergolkar, V. Gopalkrishna and S.D. Chitambar. 2013. Characterization of the non-polio enterovirus infections associated with acute flaccid paralysis in South-Western India. PLoS One 8(4): e61650.
• Leitch E.C., H. Harvala, I. Robertson, I. Ubillos, K. Templeton and P. Simmonds. 2009. Direct identification of human enterovirus serotypes in cerebrospinal fluid by amplification and sequencing of the VP1 region. J. Clin. Virol. 44: 119–124.
• Liu C.C., H.W. Tseng, S.M. Wang and I.J. Su. 2000. An outbreak of enterovirus 71 infection in Taiwan, 1998. J. Clin. Virol. 17: 23–30.
• Mehrabi Z., S. Shahmahmoodi, M.R. Eshraghian, H. Tabatabaie, M. Yousefi, Y. Mollaie, Z.S. Eshkiki, T.M. Azad and R. Nategh. 2011. Molecular detection of different types of non-polio enteroviruses in acute flaccid paralysis cases and healthy children, a pilot study. J. Clin. Virol. 50: 181–182.
• Mirand A., I. Schuffenecker, C. Henquell, G. Billaud, G. Jugie, D. Falcon, A. Mahul, C. Archimbaud, E. Terletskaia-Ladwig, S. Diedrich and others. 2010. Phylogenetic evidence for a recent spread of two populations of human enterovirus 71 in European countries. J. Gen. Virol. 91: 2263–2277.
• Odoom J.K., E. Obodai, J.S. Barnom, M. Ashun, J. Arthur-Quarm and M. Osei-Kwasi. 2012. Human Enteroviruses isolated during acute flaccid paralysis surveillance in Ghana: implications for the post eradication era. Pan. Afr. Med. J. 12:74.
• Ooi M.H., S.C. Wong, D. Clear, D. Perera, S. Krishnan, T. Preston, P.H. Tio, H.J. Willison, B. Tedman, R. Kneen and others. 2003. Adenovirus type 21-associated acute flaccid paralysis during outbreak of hand-food and mouth disease in Sarawak, Malaysia. Clin. Infect. Dis. 36: 550–559.
• Oyero O.G., F.D. Adu and J.A. Ayukekbong. 2014. Molecular characterization of diverse species enterovirus B types from children with acute flaccid paralysis and asymptomatic children in Nigeria. Virus Res. 189: 189–193.
• Saad M., S. Youssef, D. Kirschke, M. Shubair, D. Haddadin, J. Myers and J. Moorman. 2005. Acute flaccid paralysis: the spectrum of a newly recognized complication of West Nile virus infection. J. Infect. 51: 120–127.
• Shaukat S., M. Angez, M.M. Alam, S. Sharif, A. Khurshid, T. Mahmood and S.S. Zaidi. 2013. Characterization of a novel enterovirus serotype and an enterovirus EV-B93 isolated from acute flaccid paralysis patients. PloS One 8:e80040.
• Tamura K., G. Stecher, D. Peterson, A. Filipski and S. Kumar. 2013. MEGA6: molecular evolutionary genetics analysis version 6.0. Mol. Biol. Evol. 30: 2725–2729.
• WHO. 2004. Polio laboratory manual. WHO/IVB/04.10. World Health Organization, Geneva, Switzerland.
• WHO. 2015. Enterovirus surveillance guidelines. World Health Organization, Copenhagen, Denmark.
• Wieczorek M., A. Ciąćka, A. Witek, Ł. Kuryk and A. Żuk-Wasek. 2015. Environmental surveillance of non-polio enteroviruses in Poland, 2011. Food Envirol. Virol. 7(3): 224–231.

Identyfikatory

DOI

10.5604/17331331.1227670